Skip to content
Friday, 13 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Comuniq.EU

Monkeypox outbreak can be eliminated in Europe – WHO officials

epa10074094 A security personnel looks on next to a list of high-risk countries for the Monkeypox virus, as India reported the first case of Monkeypox in the WHO South-East Asia Region, at Chennai International Airport, in Chennai, India, 16 July 2022. The Tamil Nadu state public health department has started screening international passengers landing in the state of Tamil Nadu for symptoms of the Monkeypox virus as the first confirmed case of WHO South-East Asia Region has been reported in India after a traveler from Kerala who recently returned from the Middle East tested positive for the Monkeypox virus on 14 July 2022. The Tamil Nadu state government has increased the surveillance across the borders sharing with the state of Kerala and started screening at all international airports in Tamil Nadu. EPA-EFE/IDREES MOHAMMED

It is possible to eliminate the monkeypox outbreak in Europe, World Health Organization officials said on Tuesday (August 30), highlighting evidence that case counts are slowing in a handful of countries.

There are encouraging signs of a sustained week-on-week decline in the onset of cases in many European countries, including France, Germany, Portugal, Spain and Britain, as well as a slowdown in some parts of the United States, despite scarce vaccine supplies.

“We believe we can eliminate sustained human-to-human transmission of monkeypox in the (European) region,” said WHO Regional Director for Europe Hans Kluge.

The rollout of Bavarian Nordic’s BAVA.CO monkeypox vaccine has been affected by limited supply of the shot, which is also approved to prevent smallpox, although regulators are taking steps to stretch out existing stocks.

U.S., European Union and British regulators have backed changing the way the vaccine is administered by injecting a smaller amount of the shot intradermally, which increases by fivefold the doses that can be used from one vial.

In addition to the vaccine supply crunch, given the time it takes to deploy the vaccine and for it to take effect, the significant factors behind the slowdown appear to be earlier detection, which leads to patients isolating themselves sooner, and behavioural changes, Catherine Smallwood, senior emergency officer and monkeypox incident manager at WHO/Europe told a briefing.

“We do have some pretty good anecdotal evidence that people – particularly men who have sex with men who are in particular risk groups – are much more informed about the disease.”

More than 47,600 confirmed cases in 90 countries where monkeypox is not endemic have been reported since early May. The WHO has declared the outbreak a global health emergency.

Kluge and Smallwood also said that WHO anticipates a surge in Covid-19 cases in Europe for the coming autumn and winter.

There are still uncertainties regarding the behaviour of the influenza, Smallwood said.

“That it’s likely that the preventive measures that have really kept seasonal flu at bay won’t be in place in the same way that there were in 2020 and 2021. So, there will likely been into play between the different viruses. It may not be a typical flu season, we may see an atypical, it might come early, it might come a shorter period, it might come later on,” she said.

Via Reuters

Filed under Comuniq.EU

More from Comuniq.EU

More →